Yüklüyor......
A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma
LESSONS LEARNED. Pazopanib shows a modest efficacy in metastatic alveolar soft part sarcoma. Clinical outcomes were comparable to those in previous studies using antiangiogenic drugs. Further prospective studies evaluating the benefit of pazopanib in alveolar soft part sarcoma with a larger sample a...
Kaydedildi:
| Yayımlandı: | Oncologist |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Inc.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6324645/ https://ncbi.nlm.nih.gov/pubmed/30254189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0464 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|